These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 3821846

  • 41. The longest-surviving patient with classical maple syrup urine disease.
    le Roux C, Murphy E, Lilburn M, Lee PJ.
    J Inherit Metab Dis; 2006 Feb; 29(1):190-4. PubMed ID: 16601890
    [Abstract] [Full Text] [Related]

  • 42. Intermediate maple syrup urine disease: neuroimaging observations in 3 patients from South India.
    Bindu PS, Shehanaz KE, Christopher R, Pal PK, Ravishankar S.
    J Child Neurol; 2007 Jul; 22(7):911-3. PubMed ID: 17715290
    [Abstract] [Full Text] [Related]

  • 43. In response to R.E. Roux et al (2006) the longest surviving patient with classical maple syrup urine disease. J Inherit Metab Dis 29:190-194.
    Snyderman SE.
    J Inherit Metab Dis; 2006 Oct; 29(5):690. PubMed ID: 16924399
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. [Maple syrup urine disease. Genetic heterogeneity, heterozygote diagnosis and new therapeutic approach (author's transl)].
    Velázquez A, Montiel F, Sahw KN, Carnevale A, del Castillo V.
    Rev Invest Clin; 1981 Oct; 33(3):273-9. PubMed ID: 7330498
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Neuropsychometric outcome predictors for adults with maple syrup urine disease.
    le Roux C, Murphy E, Hallam P, Lilburn M, Orlowska D, Lee P.
    J Inherit Metab Dis; 2006 Feb; 29(1):201-2. PubMed ID: 16601892
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Nutritional deficiency dermatitis related to branched-chain amino acid restriction in a child with maple syrup urine disease.
    Campuzano-García AE, Castanedo-Cázares JP.
    Dermatol Online J; 2019 Sep 15; 25(9):. PubMed ID: 31738841
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Application of liquid chromatography-tandem mass spectrometry in the diagnosis and follow-up of maple syrup urine disease in a Chinese population.
    Lin N, Ye J, Qiu W, Han L, Zhang H, Gu X.
    J Pediatr Endocrinol Metab; 2013 Sep 15; 26(5-6):433-9. PubMed ID: 23412862
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Unique EEG pattern (comb-like rhythm) in neonatal maple syrup urine disease.
    Tharp BR.
    Pediatr Neurol; 1992 Sep 15; 8(1):65-8. PubMed ID: 1558579
    [Abstract] [Full Text] [Related]

  • 60. The utility of dried blood spot monitoring of branched-chain amino acids for maple syrup urine disease: A retrospective chart review study.
    Kaur J, Nagy L, Wan B, Saleh H, Schulze A, Raiman J, Inbar-Feigenberg M.
    Clin Chim Acta; 2020 Jan 15; 500():195-201. PubMed ID: 31678570
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.